BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34279803)

  • 1. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    J Nucl Cardiol; 2021 Aug; 28(4):1763-1767. PubMed ID: 34279803
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    J Nucl Cardiol; 2021 Aug; 28(4):1761-1762. PubMed ID: 34259978
    [No Abstract]   [Full Text] [Related]  

  • 3. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    Circ Cardiovasc Imaging; 2021 Jul; 14(7):e000030. PubMed ID: 34196222
    [No Abstract]   [Full Text] [Related]  

  • 4. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    J Nucl Cardiol; 2019 Dec; 26(6):2065-2123. PubMed ID: 31468376
    [No Abstract]   [Full Text] [Related]  

  • 5. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    J Nucl Cardiol; 2020 Apr; 27(2):659-673. PubMed ID: 31468377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    J Nucl Cardiol; 2021 Aug; 28(4):1769-1774. PubMed ID: 34196911
    [No Abstract]   [Full Text] [Related]  

  • 7. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    J Card Fail; 2022 Jul; 28(7):e1-e4. PubMed ID: 34217819
    [No Abstract]   [Full Text] [Related]  

  • 8. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    Circ Cardiovasc Imaging; 2021 Jul; 14(7):e000029. PubMed ID: 34196223
    [No Abstract]   [Full Text] [Related]  

  • 9. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    J Card Fail; 2019 Nov; 25(11):854-865. PubMed ID: 31473267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.
    Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM
    J Card Fail; 2019 Nov; 25(11):e1-e39. PubMed ID: 31473268
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac Amyloidosis Imaging, Part 2: Quantification and Technical Considerations.
    Schockling EJ; Farrell MB; Embry-Dierson M; Warren J; Jerome S
    J Nucl Med Technol; 2023 Jun; 51(2):90-98. PubMed ID: 37268318
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Bourque JM; Birgersdotter-Green U; Bravo PE; Budde RPJ; Chen W; Chu VH; Dilsizian V; Erba PA; Gallegos Kattan C; Habib G; Hyafil F; Khor YM; Manlucu J; Mason PK; Miller EJ; Moon MR; Parker MW; Pettersson G; Schaller RD; Slart RHJA; Strom JB; Wilkoff BL; Williams A; Woolley AE; Zwischenberger BA; Dorbala S
    JACC Cardiovasc Imaging; 2024 Jun; 17(6):669-701. PubMed ID: 38466252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS.
    Bourque JM; Birgersdotter-Green U; Bravo PE; Budde RPJ; Chen W; Chu VH; Dilsizian V; Erba PA; Gallegos Kattan C; Habib G; Hyafil F; Khor YM; Manlucu J; Mason PK; Miller EJ; Moon MR; Parker MW; Pettersson G; Schaller RD; Slart RHJA; Strom JB; Wilkoff BL; Williams A; Woolley AE; Zwischenberger BA; Dorbala S
    Clin Infect Dis; 2024 Mar; ():. PubMed ID: 38466039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease.
    ; Winchester DE; Maron DJ; Blankstein R; Chang IC; Kirtane AJ; Kwong RY; Pellikka PA; Prutkin JM; Russell R; Sandhu AT
    J Am Coll Cardiol; 2023 Jun; 81(25):2445-2467. PubMed ID: 37245131
    [No Abstract]   [Full Text] [Related]  

  • 15. 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease: A Summary for JASE.
    Chang IC; Pellikka PA; Winchester DE
    J Am Soc Echocardiogr; 2024 Mar; 37(3):303-306. PubMed ID: 37858904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
    Wolk MJ; Bailey SR; Doherty JU; Douglas PS; Hendel RC; Kramer CM; Min JK; Patel MR; Rosenbaum L; Shaw LJ; Stainback RF; Allen JM;
    J Am Coll Cardiol; 2014 Feb; 63(4):380-406. PubMed ID: 24355759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American CollegeĀ of Cardiology Appropriate Use Criteria Task Force.
    ; Rybicki FJ; Udelson JE; Peacock WF; Goldhaber SZ; Isselbacher EM; Kazerooni E; Kontos MC; Litt H; Woodard PK; ;
    J Am Coll Radiol; 2016 Feb; 13(2):e1-e29. PubMed ID: 26810814
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement and problems in appropriate use of cardiac CT: 2003, 2007 and 2011 use of CT-based on ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac CT.
    Ozawa K; Funabashi N; Takaoka H; Kobayashi Y
    Int J Cardiol; 2014 Jun; 174(2):385-8. PubMed ID: 24784915
    [No Abstract]   [Full Text] [Related]  

  • 19. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
    Ronan G; Wolk MJ; Bailey SR; Doherty JU; Douglas PS; Hendel RC; Kramer CM; Min JK; Patel MR; Rosenbaum L; Shaw LJ; Stainback RF; Allen JM; Brindis RG; Kramer CM; Shaw LJ; Cerqueira MD; Chen J; Dean LS; Fazel R; Hundley WG; Itchhaporia D; Kligfield P; Lockwood R; Marine JE; McCully RB; Messer JV; O'Gara PT; Shemin RJ; Wann LS; Wong JB; Patel MR; Kramer CM; Bailey SR; Brown AS; Doherty JU; Douglas PS; Hendel RC; Lindsay BD; Min JK; Shaw LJ; Stainback RF; Wann LS; Wolk MJ; Allen JM
    J Nucl Cardiol; 2014 Feb; 21(1):192-220. PubMed ID: 24374980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Society for Cardiovascular Magnetic Resonance perspective on the ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 multi-modality appropriate use criteria for the detection and risk assessment of chronic coronary disease.
    Bandettini WP; Kwong RY; Patel AR; Plein S;
    J Cardiovasc Magn Reson; 2023 Oct; 25(1):59. PubMed ID: 37858255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.